Table 5 PARP1 genotypes and hematological toxicities.

From: Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy

Variables

Neutropenia

Thrombocytopenia

Anemia

Rs1136410

P

HR (95%CI)

P

HR (95%CI)

P

HR (95%CI)

TT

 

1(Ref)

 

1(Ref)

 

1(Ref)

TC

0.635

0.880 (0.519–1.492)

0.212

0.521 (0.187–1.451)

0.832

0.895 (0.321–2.494)

CC

0.550

0.803 (0.392–1.646)

0.477

1.491 (0.496–4.487)

0.067

2.762 (0.932–8.183)

rs11801168

TT

 

1(Ref)

 

1(Ref)

 

1(Ref)

TC

0.991

1.009 (0.209–4.859)

0.845

0.800 (0.085–7.529)

0.640

0.581 (0.060–5.659)

CC

0.644

0.699 (0.152–3.203)

0.443

0.424 (0.047–3.789)

0.609

0.567 (0.064–4.986)

Rs12568297

GG

 

1(Ref)

 

1(Ref)

 

1(Ref)

GC

0.442

1.301 (0.666–2.541)

0.269

1.823 (0.629–5.286)

0.378

1.605 (0.560–4.596)

CC

0.646

1.527 (0.250–9.312)

0.301

3.281 (0.346–31.116)

0.354

2.889 (0.306–27.234)

Rs6664761

TT

 

1(Ref)

 

1(Ref)

 

1(Ref)

TC

0.370

1.427 (0.655–3.108)

0.313

2.936 (0.362–23.808)

0.313

2.936 (0.362–23.808)

CC

0.307

1.500 (0.689–3.265)

0.270

3.229 (0.402–25.971)

0.199

3.888 (0.490–30.870)

Rs7531668

TT

 

1(Ref)

 

1(Ref)

 

1(Ref)

TA

0.900

0.966 (0.563–1.658)

0.698

0.822 (0.306–2,208)

0.500

0.716 (0.271–1.893)

AA

0.299

0.663 (0.305–1.441)

0.290

0.329 (0.042–2.585)

0.233

0.286 (0.037–2.234)

  1. Abbreviations: HR, hazard ratios; CI, confidence interval; Ref, reference.